In the last 12 months, insiders at KYNTRA BIO, INC. ($KYNB) filed 192 transactions with the SEC: 8 open-market purchases totaling $430,291 and 58 sales totaling $4,570,198. Net insider sentiment: net selling.
KYNTRA BIO, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Conterno Enrique A (Chief Executive Officer) — 13 transactions totaling $1,777,609
- Chung Christine (SVP, China Operations) — 20 transactions totaling $808,361
- Eisner Mark (Chief Medical Officer) — 9 transactions totaling $559,004
- Wettig Thane (Chief Commercial Officer) — 20 transactions totaling $377,345
- Wettig Thane (CEO) — 29 transactions totaling $316,814
View all SEC Filings for KYNTRA BIO, INC. (KYNB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Wettig Thane | CEO | F | Common Stock | 277 | $6.84 | 24,443.0000 | 78,000,000 | 1.12% | 0.00% |
| March 6, 2026 | DeLucia David | Chief Financial Officer | F | Common Stock | 60 | $6.84 | 4,429.0000 | 78,000,000 | 1.34% | 0.00% |
| Feb. 3, 2026 | DeLucia David | Chief Financial Officer | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 78,000,000 | 9999.99% | 0.03% |
| Feb. 3, 2026 | Wettig Thane | CEO | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 78,000,000 | 9999.99% | 0.08% |
| Dec. 6, 2025 | DeLucia David | Chief Financial Officer | F | Common Stock | 52 | $8.42 | 4,489.0000 | 78,000,000 | 1.15% | 0.00% |
| Dec. 6, 2025 | Wettig Thane | CEO | F | Common Stock | 259 | $8.42 | 24,720.0000 | 78,000,000 | 1.04% | 0.00% |
| Nov. 17, 2025 | Wettig Thane | CEO | P | Common Stock | 2700 | $9.10 | 24,979.0000 | 78,000,000 | 12.12% | 0.00% |
| Nov. 13, 2025 | Wettig Thane | CEO | P | Common Stock | 1000 | $9.18 | 22,279.0000 | 78,000,000 | 4.70% | 0.00% |
| Sept. 6, 2025 | Wettig Thane | CEO | F | Common Stock | 248 | $12.10 | 21,279.0000 | 101,100,000 | 1.15% | 0.00% |
| June 6, 2025 | Wettig Thane | CEO | F | Common Stock | 246 | $7.83 | 21,527.0000 | 100,917,000 | 1.13% | 0.00% |
| Sept. 6, 2025 | DeLucia David | Chief Financial Officer | F | Common Stock | 53 | $12.10 | 4,541.0000 | 101,100,000 | 1.15% | 0.00% |
| June 6, 2025 | DeLucia David | Chief Financial Officer | F | Common Stock | 51 | $7.83 | 4,594.0000 | 100,917,000 | 1.10% | 0.00% |
| June 30, 2025 | Schoeneck James A | Not found | P | Common Stock | 23567 | $5.07 | 39,666.0000 | 101,100,000 | 146.39% | 0.02% |
| June 4, 2025 | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 100,917,000 | 9999.99% | 0.12% |
| June 4, 2025 | Kauffman Michael | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 100,917,000 | 9999.99% | 0.12% |
| June 4, 2025 | Kauffman Michael | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 100,917,000 | 9999.99% | 0.07% |
| June 4, 2025 | Schoeneck James A | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 100,917,000 | 9999.99% | 0.12% |
| June 4, 2025 | EDWARDS JEFFREY L | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 100,917,000 | 9999.99% | 0.12% |
| March 24, 2025 | Wettig Thane | CEO | P | Common Stock | 145000 | $0.35 | 544,329.0000 | 100,917,000 | 36.31% | 0.14% |
| March 21, 2025 | Schoeneck James A | Not found | P | Common Stock | 50000 | $0.34 | 402,488.0000 | 100,917,000 | 14.18% | 0.05% |
| March 20, 2025 | Schoeneck James A | Not found | P | Common Stock | 250000 | $0.35 | 352,488.0000 | 100,917,000 | 243.93% | 0.25% |
| March 6, 2025 | DeLucia David | Chief Financial Officer | F | Common Stock | 2325 | $0.39 | 116,137.0000 | 100,917,000 | 1.96% | 0.00% |
| March 6, 2025 | Chung Christine | SVP, CHINA OPERATIONS | A | Common Stock | 781 | $0.00 | 295,325.0000 | 100,917,000 | 0.27% | 0.00% |
| March 6, 2025 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 7008 | $0.39 | 294,544.0000 | 100,917,000 | 2.32% | 0.01% |
| March 6, 2025 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 422 | $0.39 | 294,903.0000 | 100,917,000 | 0.14% | 0.00% |
| March 6, 2025 | Wettig Thane | CEO | F | Common Stock | 22038 | $0.39 | 398,915.0000 | 100,917,000 | 5.24% | 0.02% |
| March 6, 2025 | Wettig Thane | CEO | A | Common Stock | 781 | $0.00 | 399,696.0000 | 100,917,000 | 0.20% | 0.00% |
| March 6, 2025 | Wettig Thane | CEO | F | Common Stock | 367 | $0.39 | 399,329.0000 | 100,917,000 | 0.09% | 0.00% |
| Jan. 9, 2025 | DeLucia David | Chief Financial Officer | A | Stock Option (Right to Buy) | 525000 | $0.00 | 525,000.0000 | 100,917,000 | 9999.99% | 0.52% |
| Jan. 9, 2025 | Wettig Thane | CEO | A | Stock Option (Right to Buy) | 1300000 | $0.00 | 1,300,000.0000 | 100,917,000 | 9999.99% | 1.29% |
| Dec. 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 2792 | $0.34 | 301,552.0000 | 98,770,000 | 0.92% | 0.00% |
| Dec. 6, 2024 | Wettig Thane | CEO | F | Common Stock | 2363 | $0.34 | 420,953.0000 | 98,770,000 | 0.56% | 0.00% |
| Dec. 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1066 | $0.34 | 164,863.0000 | 98,770,000 | 0.64% | 0.00% |
| Dec. 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1446 | $0.34 | 165,929.0000 | 98,770,000 | 0.86% | 0.00% |
| Sept. 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 17395 | $0.39 | 304,344.0000 | 98,770,000 | 5.41% | 0.02% |
| Sept. 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 16050 | $0.39 | 168,440.0000 | 98,770,000 | 8.70% | 0.02% |
| Sept. 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1065 | $0.39 | 167,375.0000 | 98,770,000 | 0.63% | 0.00% |
| Sept. 6, 2024 | Wettig Thane | CEO | F | Common Stock | 2363 | $0.39 | 423,316.0000 | 98,770,000 | 0.56% | 0.00% |
| Aug. 1, 2024 | Wettig Thane | CEO | F | Common Stock | 20840 | $0.47 | 425,679.0000 | 98,770,000 | 4.67% | 0.02% |
| June 22, 2024 | Wettig Thane | CEO | F | Common Stock | 782 | $1.13 | 446,519.0000 | 98,770,000 | 0.17% | 0.00% |
| June 12, 2024 | Adib Deyaa | Chief Medical Officer | P | Common Stock | 22123 | $1.17 | 82,123.0000 | 98,770,000 | 36.87% | 0.02% |
| June 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1182 | $1.10 | 184,490.0000 | 98,770,000 | 0.64% | 0.00% |
| June 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 17797 | $1.19 | 185,672.0000 | 98,770,000 | 8.75% | 0.02% |
| June 6, 2024 | Wettig Thane | CEO | F | Common Stock | 2255 | $1.19 | 447,301.0000 | 98,770,000 | 0.50% | 0.00% |
| June 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 19289 | $1.19 | 321,739.0000 | 98,770,000 | 5.66% | 0.02% |
| June 5, 2024 | Blaug Suzanne | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 5, 2024 | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 5, 2024 | Schoeneck James A | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 5, 2024 | Lema Gerald | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 5, 2024 | Cravatt Benjamin | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 5, 2024 | EDWARDS JEFFREY L | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 5, 2024 | Brennan Aoife | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| May 1, 2024 | Wettig Thane | CEO | F | Common Stock | 20840 | $1.17 | 449,556.0000 | 98,770,000 | 4.43% | 0.02% |
| March 22, 2024 | Wettig Thane | CEO | F | Common Stock | 782 | $2.58 | 470,396.0000 | 98,770,000 | 0.17% | 0.00% |
| March 7, 2024 | Wettig Thane | CEO | P | Common Stock | 50000 | $1.91 | 471,178.0000 | 98,770,000 | 11.87% | 0.05% |
| March 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | A | Common Stock | 781 | $0.00 | 205,072.0000 | 98,770,000 | 0.38% | 0.00% |
| March 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 422 | $1.87 | 204,650.0000 | 98,770,000 | 0.21% | 0.00% |
| March 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 20327 | $1.87 | 204,291.0000 | 98,770,000 | 9.05% | 0.02% |
| March 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | A | Common Stock | 781 | $0.00 | 341,450.0000 | 98,770,000 | 0.23% | 0.00% |
| March 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 23168 | $1.87 | 340,669.0000 | 98,770,000 | 6.37% | 0.02% |
| March 6, 2024 | Wettig Thane | CEO | F | Common Stock | 326 | $1.87 | 421,178.0000 | 98,770,000 | 0.08% | 0.00% |
| March 6, 2024 | Wettig Thane | CEO | A | Common Stock | 781 | $0.00 | 421,504.0000 | 98,770,000 | 0.19% | 0.00% |
| March 6, 2024 | Wettig Thane | CEO | F | Common Stock | 4209 | $1.87 | 420,723.0000 | 98,770,000 | 0.99% | 0.00% |
| March 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1181 | $1.79 | 203,469.0000 | 98,770,000 | 0.58% | 0.00% |
| March 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | F | Common Stock | 422 | $1.87 | 341,028.0000 | 98,770,000 | 0.12% | 0.00% |
| Feb. 21, 2024 | Chung Christine | SVP, CHINA OPERATIONS | A | Stock Option (Right to Buy) | 143000 | $0.00 | 143,000.0000 | 98,770,000 | 9999.99% | 0.14% |
| Feb. 21, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 260000 | $0.00 | 260,000.0000 | 98,770,000 | 9999.99% | 0.26% |
| Feb. 21, 2024 | Wettig Thane | CEO | A | Common Stock | 166000 | $0.00 | 424,932.0000 | 98,770,000 | 64.11% | 0.17% |
| Feb. 21, 2024 | Wettig Thane | CEO | A | Stock Option (Right to Buy) | 834000 | $0.00 | 834,000.0000 | 98,770,000 | 9999.99% | 0.84% |
| Feb. 21, 2024 | Chung Christine | SVP, CHINA OPERATIONS | A | Common Stock | 29000 | $0.00 | 363,837.0000 | 98,770,000 | 8.66% | 0.03% |
| Feb. 21, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | A | Common Stock | 52000 | $0.00 | 224,618.0000 | 98,770,000 | 30.12% | 0.05% |
| Feb. 1, 2024 | Wettig Thane | CEO | F | Common Stock | 23490 | $2.37 | 258,932.0000 | 98,770,000 | 8.32% | 0.02% |
| Dec. 22, 2023 | Wettig Thane | CEO | F | Common Stock | 819 | $0.76 | 282,422.0000 | 0 | 0.29% | 0.00% |
| Dec. 6, 2023 | Wettig Thane | CEO | F | Common Stock | 1680 | $0.58 | 283,241.0000 | 0 | 0.59% | 0.00% |
| Dec. 7, 2023 | Graham Juan | Chief Financial Officer | F | Common Stock | 1085 | $0.62 | 172,618.0000 | 0 | 0.62% | 0.00% |
| Dec. 6, 2023 | Chung Christine | SVP, China Operations | F | Common Stock | 18182 | $0.58 | 334,837.0000 | 0 | 5.15% | 0.00% |
| Dec. 6, 2023 | Graham Juan | Chief Financial Officer | F | Common Stock | 15573 | $0.58 | 173,703.0000 | 0 | 8.23% | 0.00% |
| Nov. 1, 2023 | Wettig Thane | CEO | F | Common Stock | 21841 | $0.55 | 284,921.0000 | 0 | 7.12% | 0.00% |
| Sept. 22, 2023 | Wettig Thane | Interim CEO | F | Common Stock | 819 | $0.79 | 306,762.0000 | 0 | 0.27% | 0.00% |
| Sept. 6, 2023 | Chung Christine | SVP, China Operations | F | Common Stock | 3308 | $0.96 | 353,019.0000 | 0 | 0.93% | 0.00% |
| Sept. 6, 2023 | Graham Juan | Chief Financial Officer | F | Common Stock | 711 | $0.96 | 190,372.0000 | 0 | 0.37% | 0.00% |
| Sept. 7, 2023 | Graham Juan | Chief Financial Officer | F | Common Stock | 1096 | $0.99 | 189,276.0000 | 0 | 0.58% | 0.00% |
| Sept. 6, 2023 | Wettig Thane | Interim CEO | F | Common Stock | 1680 | $0.96 | 307,581.0000 | 0 | 0.54% | 0.00% |
| Sept. 6, 2023 | Eisner Mark | EVP, Chief Medical Officer | F | Common Stock | 1860 | $0.96 | 159,917.0000 | 0 | 1.15% | 0.00% |
| Sept. 1, 2023 | Eisner Mark | EVP, Chief Medical Officer | F | Common Stock | 1085 | $1.06 | 161,777.0000 | 0 | 0.67% | 0.00% |
| Sept. 1, 2023 | Henderson Jeffrey William | Director | S | Common Stock | 2000 | $1.03 | 28,866.0000 | 0 | 6.48% | 0.00% |
| Aug. 30, 2023 | Graham Juan | Chief Financial Officer | A | Common Stock | 120000 | $0.00 | 191,083.0000 | 0 | 168.82% | 0.00% |
| Aug. 30, 2023 | Chung Christine | SVP, China Operations | A | Stock Option (Right to Buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 30, 2023 | Chung Christine | SVP, China Operations | A | Common Stock | 120000 | $0.00 | 356,327.0000 | 0 | 50.78% | 0.00% |
| Aug. 30, 2023 | Graham Juan | Chief Financial Officer | A | Stock Option (Right to Buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Schoeneck James A | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 7, 2023 | Wettig Thane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 7, 2023 | Wettig Thane | Chief Commercial Officer | A | Common Stock | 200000 | $0.00 | 308,261.0000 | 0 | 184.74% | 0.00% |
| Aug. 4, 2023 | Henderson Jeffrey William | Director | S | Common Stock | 2000 | $1.91 | 30,866.0000 | 0 | 6.09% | 0.00% |
| July 11, 2023 | Henderson Jeffrey William | Director | S | Common Stock | 2000 | $2.69 | 32,866.0000 | 0 | 5.74% | 0.00% |
| July 7, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 1880 | $2.80 | 402,522.0000 | 0 | 0.46% | 0.00% |
| June 23, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 791 | $16.53 | 108,261.0000 | 0 | 0.73% | 0.00% |
| June 7, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 1286 | $17.04 | 109,052.0000 | 0 | 1.17% | 0.00% |
| June 7, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 472 | $17.04 | 110,338.0000 | 0 | 0.43% | 0.00% |
| June 14, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 5250 | $16.66 | 237,327.0000 | 0 | 2.16% | 0.00% |
| June 13, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 6250 | $17.60 | 242,577.0000 | 0 | 2.51% | 0.00% |
| June 14, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 1000 | $17.46 | 236,327.0000 | 0 | 0.42% | 0.00% |
| June 7, 2023 | Schoeneck James A | Director | A | Common Stock | 8289 | $0.00 | 102,488.0000 | 0 | 8.80% | 0.00% |
| June 7, 2023 | Cravatt Benjamin | Director | A | Common Stock | 8289 | $0.00 | 32,680.0000 | 0 | 33.98% | 0.00% |
| June 9, 2023 | Cravatt Benjamin | Director | S | Common Stock | 1766 | $16.75 | 30,914.0000 | 0 | 5.40% | 0.00% |
| June 9, 2023 | Cravatt Benjamin | Director | S | Common Stock | 2178 | $17.51 | 28,736.0000 | 0 | 7.05% | 0.00% |
| June 7, 2023 | Cravatt Benjamin | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Brennan Aoife | Director | A | Common Stock | 8289 | $0.00 | 32,680.0000 | 0 | 33.98% | 0.00% |
| June 9, 2023 | Brennan Aoife | Director | S | Common Stock | 1994 | $16.74 | 30,686.0000 | 0 | 6.10% | 0.00% |
| June 9, 2023 | Brennan Aoife | Director | S | Common Stock | 2739 | $17.52 | 27,947.0000 | 0 | 8.93% | 0.00% |
| June 7, 2023 | Brennan Aoife | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Blaug Suzanne | Director | A | Common Stock | 8289 | $0.00 | 38,114.0000 | 0 | 27.79% | 0.00% |
| June 9, 2023 | Blaug Suzanne | Director | S | Common Stock | 3351 | $16.73 | 34,763.0000 | 0 | 8.79% | 0.00% |
| June 9, 2023 | Blaug Suzanne | Director | S | Common Stock | 5169 | $17.51 | 29,594.0000 | 0 | 14.87% | 0.00% |
| June 7, 2023 | Blaug Suzanne | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Ho Maykin | Director | A | Common Stock | 8289 | $0.00 | 40,021.0000 | 0 | 26.12% | 0.00% |
| June 8, 2023 | Ho Maykin | Director | S | Common Stock | 2295 | $16.79 | 37,726.0000 | 0 | 5.73% | 0.00% |
| June 8, 2023 | Ho Maykin | Director | S | Common Stock | 6225 | $17.68 | 31,501.0000 | 0 | 16.50% | 0.00% |
| June 7, 2023 | Ho Maykin | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Lema Gerald | Director | A | Common Stock | 8289 | $0.00 | 45,366.0000 | 0 | 22.36% | 0.00% |
| June 7, 2023 | Lema Gerald | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | EDWARDS JEFFREY L | Director | A | Common Stock | 8289 | $0.00 | 41,866.0000 | 0 | 24.69% | 0.00% |
| June 9, 2023 | EDWARDS JEFFREY L | Director | S | Common Stock | 3265 | $16.74 | 38,601.0000 | 0 | 7.80% | 0.00% |
| June 9, 2023 | EDWARDS JEFFREY L | Director | S | Common Stock | 4624 | $17.51 | 33,977.0000 | 0 | 11.98% | 0.00% |
| June 7, 2023 | EDWARDS JEFFREY L | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Henderson Jeffrey William | Director | A | Common Stock | 8289 | $0.00 | 41,866.0000 | 0 | 24.69% | 0.00% |
| June 8, 2023 | Henderson Jeffrey William | Director | S | Common Stock | 2006 | $16.87 | 39,860.0000 | 0 | 4.79% | 0.00% |
| June 8, 2023 | Henderson Jeffrey William | Director | S | Common Stock | 4994 | $17.69 | 34,866.0000 | 0 | 12.53% | 0.00% |
| June 7, 2023 | Henderson Jeffrey William | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Schoeneck James A | Director | S | Common Stock | 7100 | $18.03 | 102,488.0000 | 0 | 6.48% | 0.00% |
| June 7, 2023 | Schoeneck James A | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Graham Juan | Chief Financial Officer | S | Common Stock | 1050 | $16.95 | 71,818.0000 | 0 | 1.44% | 0.00% |
| June 7, 2023 | Graham Juan | Chief Financial Officer | S | Common Stock | 735 | $17.04 | 71,083.0000 | 0 | 1.02% | 0.00% |
| June 7, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 1362 | $17.04 | 251,098.0000 | 0 | 0.54% | 0.00% |
| June 7, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 739 | $17.04 | 250,359.0000 | 0 | 0.29% | 0.00% |
| June 7, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 1532 | $17.04 | 248,827.0000 | 0 | 0.61% | 0.00% |
| June 7, 2023 | Eisner Mark | EVP, Chief Medical Officer | S | Common Stock | 2042 | $17.04 | 162,862.0000 | 0 | 1.24% | 0.00% |
| June 7, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 2791 | $17.04 | 410,508.0000 | 0 | 0.68% | 0.00% |
| June 7, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 6106 | $17.04 | 404,402.0000 | 0 | 1.49% | 0.00% |
| June 7, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 472 | $17.04 | 112,681.0000 | 0 | 0.42% | 0.00% |
| June 7, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 1286 | $17.04 | 111,395.0000 | 0 | 1.14% | 0.00% |
| June 2, 2023 | Eisner Mark | EVP, Chief Medical Officer | S | Common Stock | 1090 | $18.83 | 164,904.0000 | 0 | 0.66% | 0.00% |
| April 10, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 1869 | $19.52 | 410,799.0000 | 0 | 0.45% | 0.00% |
| April 4, 2023 | Eisner Mark | Chief Medical Officer | S | Common Stock | 9182 | $18.78 | 165,994.0000 | 0 | 5.24% | 0.00% |
| April 4, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 6590 | $18.78 | 252,460.0000 | 0 | 2.54% | 0.00% |
| March 20, 2023 | Wettig Thane | Chief Commercial Officer | G | Common Stock | 2343 | $0.00 | 109,310.0000 | 0 | 2.10% | 0.00% |
| March 20, 2023 | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1000 | $0.00 | 109,310.0000 | 0 | 0.92% | 0.00% |
| March 23, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 905 | $18.71 | 110,653.0000 | 0 | 0.81% | 0.00% |
| March 10, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 19489 | $20.20 | 384,868.0000 | 0 | 4.82% | 0.00% |
| March 8, 2023 | Graham Juan | Chief Financial Officer | S | Common Stock | 2749 | $21.16 | 70,213.0000 | 0 | 3.77% | 0.00% |
| March 8, 2023 | Graham Juan | Chief Financial Officer | A | Common Stock | 2899 | $0.00 | 73,112.0000 | 0 | 4.13% | 0.00% |
| March 8, 2023 | Graham Juan | Chief Financial Officer | A | Common Stock | 4668 | $0.00 | 77,780.0000 | 0 | 6.38% | 0.00% |
| March 10, 2023 | Graham Juan | Chief Financial Officer | S | Common Stock | 1112 | $20.20 | 76,668.0000 | 0 | 1.43% | 0.00% |
| March 8, 2023 | Chung Christine | SVP, China Operations | A | Common Stock | 9338 | $0.00 | 266,656.0000 | 0 | 3.63% | 0.00% |
| March 10, 2023 | Graham Juan | Chief Financial Officer | S | Common Stock | 2344 | $20.20 | 72,868.0000 | 0 | 3.12% | 0.00% |
| March 8, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 6265 | $21.16 | 104,090.0000 | 0 | 5.68% | 0.00% |
| March 8, 2023 | Wettig Thane | Chief Commercial Officer | A | COmmon Stock | 5799 | $0.00 | 109,889.0000 | 0 | 5.57% | 0.00% |
| March 8, 2023 | Wettig Thane | Chief Commercial Officer | A | Common Stock | 9338 | $0.00 | 119,227.0000 | 0 | 8.50% | 0.00% |
| March 10, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 2938 | $20.20 | 116,289.0000 | 0 | 2.46% | 0.00% |
| March 10, 2023 | Wettig Thane | Chief Commercial Officer | S | Common Stock | 4731 | $20.20 | 111,558.0000 | 0 | 4.07% | 0.00% |
| March 10, 2023 | Graham Juan | Chief Financial Officer | S | Common Stock | 1456 | $20.20 | 75,212.0000 | 0 | 1.90% | 0.00% |
| March 10, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 4692 | $20.20 | 261,964.0000 | 0 | 1.76% | 0.00% |
| March 10, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 2914 | $20.20 | 259,050.0000 | 0 | 1.11% | 0.00% |
| March 8, 2023 | Eisner Mark | Chief Medical Officer | S | Common Stock | 7363 | $21.16 | 165,133.0000 | 0 | 4.27% | 0.00% |
| March 8, 2023 | Eisner Mark | Chief Medical Officer | A | Common Stock | 7732 | $0.00 | 172,865.0000 | 0 | 4.68% | 0.00% |
| March 8, 2023 | Eisner Mark | Chief Medical Officer | A | Common Stock | 12451 | $0.00 | 185,316.0000 | 0 | 7.20% | 0.00% |
| March 10, 2023 | Eisner Mark | Chief Medical Officer | S | Common Stock | 3885 | $20.20 | 181,431.0000 | 0 | 2.10% | 0.00% |
| March 10, 2023 | Eisner Mark | Chief Medical Officer | S | Common Stock | 6255 | $20.20 | 175,176.0000 | 0 | 3.45% | 0.00% |
| March 10, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 19486 | $20.20 | 412,668.0000 | 0 | 4.51% | 0.00% |
| March 8, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 24672 | $21.16 | 383,911.0000 | 0 | 6.04% | 0.00% |
| March 8, 2023 | Conterno Enrique A | Chief Executive Officer | A | Common Stock | 23120 | $0.00 | 407,031.0000 | 0 | 6.02% | 0.00% |
| March 8, 2023 | Conterno Enrique A | Chief Executive Officer | A | Common Stock | 37229 | $0.00 | 444,260.0000 | 0 | 9.15% | 0.00% |
| March 10, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 12103 | $20.20 | 432,157.0000 | 0 | 2.72% | 0.00% |
| March 8, 2023 | Chung Christine | SVP, China Operations | S | Common Stock | 8354 | $21.16 | 251,519.0000 | 0 | 3.21% | 0.00% |
| March 8, 2023 | Chung Christine | SVP, China Operations | A | Common Stock | 5799 | $0.00 | 257,318.0000 | 0 | 2.31% | 0.00% |
| March 2, 2023 | Eisner Mark | Chief Medical Officer | S | Common Stock | 1187 | $21.87 | 172,496.0000 | 0 | 0.68% | 0.00% |
| Feb. 21, 2023 | Graham Juan | Chief Financial Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Graham Juan | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 72,962.0000 | 0 | 52.12% | 0.00% |
| Feb. 21, 2023 | Wettig Thane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Wettig Thane | Chief Commercial Officer | A | Common Stock | 25000 | $0.00 | 110,355.0000 | 0 | 29.29% | 0.00% |
| Feb. 21, 2023 | Chung Christine | SVP, China Operations | A | Common Stock | 25000 | $0.00 | 259,873.0000 | 0 | 10.64% | 0.00% |
| Feb. 21, 2023 | Eisner Mark | Chief Medical Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Conterno Enrique A | Chief Executive Officer | A | Common Stock | 85300 | $0.00 | 408,583.0000 | 0 | 26.39% | 0.00% |
| Feb. 21, 2023 | Conterno Enrique A | Chief Executive Officer | A | Stock Option (Right to Buy) | 143100 | $0.00 | 143,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Eisner Mark | Chief Medical Officer | A | Common Stock | 32500 | $0.00 | 173,683.0000 | 0 | 23.02% | 0.00% |
| Feb. 21, 2023 | Chung Christine | SVP, China Operations | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2022 | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1820 | $0.00 | 85,355.0000 | 0 | 2.09% | 0.00% |
| May 25, 2022 | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1988 | $0.00 | 87,175.0000 | 0 | 2.23% | 0.00% |
| May 25, 2022 | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1988 | $0.00 | 87,175.0000 | 0 | 2.23% | 0.00% |
| Jan. 6, 2023 | Conterno Enrique A | Chief Executive Officer | S | Common Stock | 1538 | $19.95 | 323,283.0000 | 0 | 0.47% | 0.00% |
| Dec. 8, 2022 | Chung Christine | SVP, China Operations | S | Common Stock | 2595 | $15.79 | 234,873.0000 | 0 | 1.09% | 0.00% |
| Sept. 6, 2022 | Chung Christine | SVP, China Operations | F | Common Stock | 1851 | $12.26 | 242,151.0000 | 0 | 0.76% | 0.00% |